Halozyme Therapeutics, Inc. (HALO) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
HALO Historical Performance
Short-Term Returns
HALO Stock Price Trajectory (2011–2026)
As of May 8, 2026, Halozyme Therapeutics, Inc. (HALO) trades at $65.19, representing a -7.1% return over the past year. The stock has delivered a +37.0% total return over five years (+6.5% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $82.22 on February 9, 2026. From this peak, HALO has corrected -20.7%, currently trading 5% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers ALNY (+7.0% 1Y), IONS (+129.9% 1Y), and ARWR (+496.9% 1Y), HALO has underperformed the peer group average. Compare HALO vs ALNY →
HALO Historical Price Data (2025–2026)
Showing 30 of 3,650 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 65.92 | 67.66 | 64.45 | 65.19 | 1.43M | -1.75% |
| 2026-05-06 | 66.80 | 67.28 | 65.64 | 66.35 | 821K | +0.73% |
| 2026-05-05 | 65.35 | 67.35 | 64.56 | 65.87 | 1.23M | +2.01% |
| 2026-05-04 | 63.74 | 64.68 | 63.11 | 64.57 | 818K | +0.95% |
| 2026-05-01 | 63.48 | 64.31 | 62.38 | 63.96 | 814K | +0.47% |
| 2026-04-30 | 63.21 | 64.33 | 63.10 | 63.66 | 1.13M | +0.95% |
| 2026-04-29 | 63.28 | 64.23 | 62.90 | 63.06 | 1.03M | -1.25% |
| 2026-04-28 | 65.27 | 65.28 | 62.59 | 63.86 | 1.30M | -0.98% |
| 2026-04-27 | 65.40 | 66.66 | 64.16 | 64.49 | 1.31M | -1.33% |
| 2026-04-24 | 66.31 | 66.44 | 64.80 | 65.36 | 1.35M | -1.85% |
| 2026-04-23 | 68.89 | 70.32 | 66.45 | 66.59 | 2.36M | -2.65% |
| 2026-04-22 | 68.54 | 69.09 | 67.94 | 68.40 | 834K | -0.01% |
| 2026-04-21 | 69.57 | 70.02 | 68.24 | 68.41 | 1.52M | -1.67% |
| 2026-04-20 | 69.34 | 70.31 | 69.01 | 69.57 | 1.17M | +0.40% |
| 2026-04-17 | 67.43 | 69.44 | 67.20 | 69.29 | 1.67M | +3.98% |
| 2026-04-16 | 68.04 | 68.84 | 66.36 | 66.64 | 1.54M | -2.07% |
| 2026-04-15 | 67.33 | 68.33 | 67.11 | 68.05 | 1.15M | +1.10% |
| 2026-04-14 | 66.61 | 68.33 | 66.54 | 67.31 | 1.42M | +0.49% |
| 2026-04-13 | 67.53 | 68.05 | 66.20 | 66.98 | 973K | -1.24% |
| 2026-04-10 | 67.34 | 68.23 | 66.64 | 67.82 | 981K | +1.10% |
| 2026-04-09 | 65.31 | 67.52 | 65.22 | 67.08 | 1.23M | +2.52% |
| 2026-04-08 | 64.71 | 65.67 | 64.05 | 65.43 | 1.67M | +2.88% |
| 2026-04-07 | 62.99 | 64.20 | 62.27 | 63.60 | 1.14M | +0.82% |
| 2026-04-06 | 64.56 | 64.69 | 62.69 | 63.08 | 1.23M | -2.19% |
| 2026-04-02 | 64.04 | 65.65 | 63.61 | 64.49 | 1.21M | -1.39% |
| 2026-04-01 | 65.14 | 66.00 | 64.46 | 65.40 | 1.35M | +1.19% |
| 2026-03-31 | 62.95 | 64.89 | 62.71 | 64.63 | 1.44M | +4.02% |
| 2026-03-30 | 61.94 | 62.21 | 61.50 | 62.13 | 911K | +0.81% |
| 2026-03-27 | 63.12 | 63.15 | 61.34 | 61.63 | 1.25M | -2.62% |
| 2026-03-26 | 63.05 | 64.00 | 62.68 | 63.29 | 710K | +0.08% |
See HALO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HALO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HALO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHALO — Frequently Asked Questions
Quick answers to the most common questions about buying HALO stock.
How has HALO stock performed recently?
HALO declined -7.1% over the past year, below its 5-year annualized CAGR of +6.5%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is HALO's all-time high price?
Halozyme Therapeutics, Inc. reached $82.22 on 2026-02-09. The 52-week high is $82.22. Current 1-year return of -7.1% places the stock further from historical peaks.
Where can I download HALO historical price data?
This page provides HALO daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.